Prof. Xing Chang

Vice Dean, Graduate Studies, School of Medicine

Associate Professor, School of Medicine/School of Life Sciences

Westlake University

biography

Professor Chang received his B.Sc. (2001) from Peking University and his Ph.D (2006) from Ohio State University. After completing his postdoctoral training (2011) at Yale University, he worked as an instructor at La Jolla Institute for Allergy and  Immunology, and then started his own research lab at Shanghai Institutes for  Biological Sciences, Chinese Academy of Sciences. In 2018, Dr. Chang joined  Westlake University as an associate professor. Dr. Chang is investigating  molecular mechanisms regulating lymphocyte development. Based on unique mechanisms of lymphocyte development, he is also developing incisive new tools to increase our understanding of biology and to discover treatments for human disease. His work led to many peer-reviewed publications,  including Immunity (2018,2011), Molecular Cell (2018), Science Signaling (2017), Nature Methods (2016), eLife (2016), PNAS (2015), JEM (2005,2006).

Title

Translating Immunology into Therapeutics for Genetic Diseases

abstract

Immune responses can amplify tissue damage caused by genetic defects, creating therapeutic opportunities beyond gene correction. Using Duchenne muscular dystrophy (DMD) as a model, this presentation explores how mechanistic immunology can guide treatment development. Our studies identify early IgG accumulation on dystrophin-deficient muscle fibers, associated with aberrant FcγRI expression. This interaction promotes myofiber IL-6 production and inflammatory macrophage responses. Anti-CD20-mediated B cell depletion reduces intramuscular IgG accumulation, alleviates muscle pathology, and improves function in two mouse models. A small nonhuman primate study provides additional preclinical support, with variable functional responses. These findings support further evaluation of immune-directed therapies for DMD and illustrate a broader strategy for treating genetic diseases by targeting immune mechanisms shared across disease-causing mutations.